africae and African tick-bite fever
have not previously been reported in Senegal, and few positive human serum samples have been documented in western Africa.
The patient was treated with doxycycline 200 mg/day for 1 week for suspected African tick-bite fever.
africae and confirmed the diagnosis of African tick-bite fever.
African tick-bite fever (ATBF), a recently rediscovered rickettsiosis of the spotted fever group, is caused by Rickettsia africae, an obligate intracellular, gram-negative, rod-shaped bacterium, transmitted by cattle ticks of the Amblyomma genus (1-5).
African tick-bite fever imported into Norway: presentation of 8 cases.
Rickettsia africae is a recently described spotted fever group (SFG) rickettsia that is the agent of African tick-bite fever
(ATBF), a mild but common tickborne disease of local persons and tourists, in particular, in sub-Saharan Africa.
The estimated incidence of African tick-bite fever
in safari travelers is 4%-5.
These findings established a diagnosis of acute rickettsiosis, most likely African tick-bite fever
africae, has been identified as the agent of African tick-bite fever
africae, which cause Mediterranean spotted fever (MSF) and African tick-bite fever
(ATBF), respectively, have been associated with human disease in the region; ATBF is more frequently associated with travel (1).